Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 20/20 | 0.77 |
| ▸ | MMP2 | P08253 | 19/20 | 0.77 |
| ▸ | MMP8 | P22894 | 17/20 | 0.77 |
| ▸ | MMP9 | P14780 | 12/20 | 0.77 |
| ▸ | MMP1 | P03956 | 5/20 | 0.77 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.77 |
| ▸ | MMP3 | P08254 | 4/20 | 0.71 |
| ▸ | MMP14 | P50281 | 2/20 | 0.61 |
| ▸ | MMP7 | P09237 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8330593 | 0.90 | MMP13 (0.78) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL8334869 | 0.90 | MMP13 (0.69) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL8321368 | 0.89 | MMP13 (0.76) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL8334433 | 0.87 | MMP13 (0.80) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL8322254 | 0.85 | MMP13 (0.76) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL6226668 | 0.84 | MMP13 (0.85) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL5919322 | 0.84 | MMP13 (0.94) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL6363229 | 0.83 | MMP13 (1.00) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL5908643 | 0.83 | MMP13 (0.77) | MMP13MMP2MMP8MMP9MMP1 | |
| SCHEMBL8321375 | 0.83 | MMP13 (0.70) | MMP13MMP2MMP8MMP9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004043943-A1 | AROMATIC SULFONE HYDROXAMIC ACIDS AND THEIR USE AS PROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |